Jayanthi Wolf

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

Thomas P. Monath, Patricia Fast, Kayvon Modjarrad et al. · Vaccine X · 2019 · 83 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates

Gokul Swaminathan, Elizabeth Thoryk, Jeffrey S. Smith et al. · Scientific Reports · 2016 · 77 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic

Beth-Ann Coller, Jeffrey T. Blue, Rituparna Das et al. · Vaccine · 2017 · 50 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency

Fubao Wang, Alan C. Puddy, Bill C. Mathis et al. · Vaccine · 2005 · 36 citations

Life Sciences, Molecular Biology, Gene Therapy +15

Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists

Rani S. Sellers, Keith Nelson, Bindu Bennet et al. · Toxicologic Pathology · 2019 · 34 citations · Full text

Veterinary Medicine, Toxicology, Veterinary Pathology +17